Hormonal profile of women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland birth cohort 1966 study.

The hormonal profiles of nested female patients (n = 500) with self-reported symptoms typical of polycystic ovary syndrome (PCOS), oligomenorrhea, and/or hirsutism and their randomly selected controls (n = 1026) at the age of 31 yr were analyzed in a general population-based Northern Finland birth cohort 1966 to find out whether the symptomatic women also have the endocrine characteristics of PCOS and could be detected in a general population using simple questions. Higher medians of serum testosterone (T) (2.10 vs. 1.90 nmol/liter, P < 0.001), LH (5.40 vs. 4.85 U/liter, P = 0.005), insulin (53.8 vs. 51.66 pmol/liter, P = 0.040), and free androgen index (FAI) (4.01 vs. 3.03, P < 0.001) and lower glucose/insulin ratio (91.1 x 10(8) vs. 94.9 x 10(8), P = 0.048) and SHBG (52.4 vs. 60.7 nmol/liter, P < 0.001) were observed among the cases, but no difference was observed in cortisol and glucose levels between the cases and controls. Of all the women in the cohort, 10.2% reported only oligomenorrhea and had biochemical findings similar to the whole case group. Those who reported only hirsutism (10.4%) were in between the case and control groups according to biochemical findings. The subjects who reported both oligomenorrhea and hirsutism (3.4%) had the highest T, LH, FAI, insulin, and glucose and the lowest SHBG and glucose/insulin ratio, compared with the case group and the groups with either symptom only indicating a dose-response manner in typical endocrine profile of PCOS by adding up symptoms. The levels of T and FAI were higher and SHBG lower in groups with overweight or obesity both at 14 and 31 yr, compared with groups with normal weight at 14 yr and overweight or obesity at 31 yr. In the group with normal weight at 14 and 31 yr and the group with overweight or obesity at 14 yr but normal weight at 31 yr, the levels of T and FAI were lowest and SHBG highest. T and FAI were higher and SHBG lower among the cases than the controls in groups stratified by weight development from adolescence to adulthood. In conclusion, this longitudinal study of a large, stable population indicates that women with self-reported symptoms of hirsutism and/or oligomenorrhea show endocrine characteristics of PCOS and can be detected in a general population using simple questions. These symptoms are markers of the underlying metabolic alterations possibly associated with increased health risks in later life.

[1]  J. Honour,et al.  HETEROGENEITY OF THE POLYCYSTIC OVARY SYNDROME: CLINICAL, ENDOCRINE AND ULTRASOUND FEATURES IN 556 PATIENTS , 1989, Clinical endocrinology.

[2]  L. Wide,et al.  The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women , 1994, Clinical endocrinology.

[3]  R. Rosenfield Current concepts of polycystic ovary syndrome. , 1997, Bailliere's clinical obstetrics and gynaecology.

[4]  S. Yen,et al.  Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease. , 1970, The Journal of clinical endocrinology and metabolism.

[5]  J. Wadsworth,et al.  POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN , 1988, The Lancet.

[6]  I. Vauhkonen,et al.  Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome , 2000 .

[7]  I. Vauhkonen,et al.  Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome. , 2000, Human reproduction.

[8]  L. Kuller,et al.  Evidence for Association Between Polycystic Ovary Syndrome and Premature Carotid Atherosclerosis in Middle-Aged Women , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[9]  D. Schoenfeld,et al.  Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. , 1997, The Journal of clinical endocrinology and metabolism.

[10]  S. Franks POLYCYSTIC OVARY SYNDROME: A CHANGING PERSPECTIVE , 1989, Clinical endocrinology.

[11]  J. L. San Millán,et al.  The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2000 by The Endocrine Society A Prospective Study of the Prevalence of the Polycystic Ovary Syndrome in Unselected Caucasian Women from Spain* , 1999 .

[12]  P. Rantakallio,et al.  The longitudinal study of the northern Finland birth cohort of 1966. , 1988, Paediatric and perinatal epidemiology.

[13]  T. Key,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1998 by The Endocrine Society Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study* , 2022 .

[14]  R. Habershon Letter: Kumidini hospital. , 1975, Lancet.

[15]  B. Çakır,et al.  Insulin Resistance in Nonobese Patients with Polycystic Ovary Syndrome , 2001, Hormone Research in Paediatrics.

[16]  J. Tapanainen,et al.  The prevalence of polycystic ovaries in healthy women , 1999, Acta obstetricia et gynecologica Scandinavica.

[17]  M. Knip,et al.  Adrenal steroidogenesis is related to insulin in hyperandrogenic women. , 1996, Fertility and sterility.

[18]  T. Bützow,et al.  Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. , 1996, The Journal of clinical endocrinology and metabolism.

[19]  S. Franks,et al.  Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism. , 1986, British medical journal.

[20]  E. Diamanti-Kandarakis,et al.  A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. , 1999, The Journal of clinical endocrinology and metabolism.

[21]  J. Nestler Sex hormone-binding globulin: a marker for hyperinsulinemia and/or insulin resistance? , 1993, The Journal of clinical endocrinology and metabolism.

[22]  A. Lanzone,et al.  Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome. , 1999, Metabolism: clinical and experimental.

[23]  J. Clore,et al.  A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. , 1991, The Journal of clinical endocrinology and metabolism.

[24]  J. L. San Millán,et al.  Receiver operating characteristic analysis of the performance of basal serum hormone profiles for the diagnosis of polycystic ovary syndrome in epidemiological studies. , 2001, European journal of endocrinology.

[25]  D. Finegood,et al.  A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. , 1998, The Journal of clinical endocrinology and metabolism.

[26]  H. Yki-Järvinen,et al.  Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. , 1995, The Journal of clinical endocrinology and metabolism.

[27]  K. Segal,et al.  Profound Peripheral Insulin Resistance, Independent of Obesity, in Polycystic Ovary Syndrome , 1989, Diabetes.

[28]  D. Apter,et al.  Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism. , 1995, The Journal of clinical endocrinology and metabolism.

[29]  J. Clore,et al.  The central role of obesity (hyperinsulinemia) in the pathogenesis of the polycystic ovary syndrome , 1989, American journal of obstetrics and gynecology.

[30]  M. Hull Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. , 1987, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[31]  B. Corenblum,et al.  Hyperinsulinemia in polycystic ovary syndrome correlates with increased cardiovascular risk independent of obesity. , 2000, Fertility and sterility.

[32]  J. Higginson,et al.  A prospective study of the prevalence of clear‐cut endocrine disorders and polycystic ovaries in 350 patients presenting with hirsutism or androgenic alopecia , 1994, Clinical endocrinology.